Abstract: Background and Aim: The incidence of acute pancreatitis is rising around the world, thus further increasing the burden on healthcare services. Approximately 10% of patients with acute pancreatitis will develop infected necrotizing pancreatitis, which is the leading cause of high mortality in the late phase. There is currently no consensus with regard to the use of endoscopic or minimally invasive surgical as the first-line therapy of choice for infected necrotizing pancreatitis. However, more clinical research regarding the superiority of the endoscopic approach has been published recently. Therefore, we conducted a systematic review and meta-analysis to determine which of the two treatments leads to a better prognosis. 
Introduction
Acute pancreatitis (AP), one of the most common gastrointestinal diseases worldwide (1) , is an inflammatory disease initiated by intra-acinar activation of proteolysis pancreatic enzymes, which causes a source of substantial service burden and hospital cost in nearly all countries (2) . The 2012 revised Atlanta classification divides AP into three clinical severity levels of mild, moderate and severe (3) . More than half of patients with AP will develop edematous pancreatitis with a mild course, which is a selflimiting disease that resolves with conservative medical management, requiring only a brief period of hospitalization (4) . Moderate severe acute pancreatitis (MSAP) and severe acute pancreatitis (SAP), often accompanied by necrosis of the (peri) pancreatic tissue or (multiple) organ failure (MOF) , is still a challenge in the medical field, even with the ever-progressing level of medical treatment (5) . Currently, there is no clear indicator of the development of severe pancreatitis. Gallstones and alcohol abuse are the main prevalent causes of AP. In addition, hyperlipidemia, hyperkalemia, anatomic variation and idiopathic acute pancreatitis (IAP) act as other indispensable factors for AP (6) . With the development of auxiliary examinations such as EUS, MRCP and CT, most incidences of IAP possess definitive etiology and could prevent recurrence of pancreatitis (7) . Implementation of cholecystectomy or endoscopic sphincterotomy effectively prevents the incidence of recurrent biliary pancreatitis (8) . The clinical course of AP can be divided into 2 phases. In the first phase, systemic inflammatory response syndrome (SIRS) and MOF occur frequently and are the main cause of death. The late phase is characterized by local complications of necrosis and pancreatic fluid collections (9) , which contain peripancreatic fluid collections, pancreatic and peripancreatic necrosis (sterile or infected), pseudocyst and walled-off necrosis (sterile or infected). Approximately 33% of patients with walled-off pancreatic necrosis (WON) and acute necrotizing pancreatitis (ANP) are often associated with infection (10) leading to bowel obstruction, bowel fistulisation, haemorrhage, prolonged hospitalization and even death (11) . Early fluid resuscitation, enteral nutrition, antibiotics and intervention are of vital importance to treat INP (12) . Surgical resection of necrosis is an essential therapy for the INP, which should be performed at least four weeks after the onset of pancreatitis. Traditionally, these fluid collections following INP were managed surgically with open trans-peritoneal debridement (13) . This approach has a mortality rate of 11.4 to 20.3% (14) . Due to the high mortality rate with open surgery, the use of endoscopic and minimally invasive techniques, such as percutaneous catheter drainage (PCD), mini incision drainage (MID), video-assisted debridement (VAD), laparoscopic transgastric drainage (LTD) and endoscopic ultrasound-guided transluminal drainage (ETD), endoscopic transgastric necrosectomy (ETG) has gained increasing popularity in many centers (15) . To date, endoscopic and MIS have been recommended as the preferred treatment of INP by an increasing number of guidelines. However, it has not yet been concluded which treatment is more effective, so the meta-analysis is necessity. In this systematic review and meta-analysis, our aim is to compare the two strategies in the treatment of INP.
Methods
Ethical approval or patient consent was not required because the present study was a review of the previous published literature.
Search strategy and study selection criteria
A computerized search spanning the years 1980 to 2018 was conducted on the Medline, Sino Med, EMBASE, and Cochrane Library databases. The following search terms were used in all possible combinations: -pancreatitis‖, -infected necrotizing pancreatitis‖, -walled off pancreatic necrosis‖, -endoscopic approach‖, -endoscopic drainage‖, -endoscopic necrosectomy‖, -surgical step-up approach‖, -minimally invasive approach‖, -randomized comparative trials‖, -prospective trials‖, and -retrospective trials‖. The detailed search strategy for each database was provided (see appendix content). The search was limited to human subjects. There was no language limitation. The titles and abstracts of potentially relevant studies identified by the computerized search were reviewed. Full-text articles were obtained for detailed evaluation, and eligible studies were included in the systematic review. The findings of NRS may also be useful to inform the design of a subsequent randomized trial. The inclusion criteria were the following: both RCTs and observational clinical trials; the study included patients who were of either sex, had a clinical diagnosis of INP; both endoscopic and MIS should be administered as the treatment, with the aim of the trial being a comparison of the endoscopic approach and MIS in treating INP; the outcomes should be clearly described including at least one of four major outcomes, such as the incidence of mortality, MOF, LOS and PF. The exclusion criteria were the following: absence of comparison between endoscopic and MIS approaches; the characteristics of patients and information data about treatment outcome, which were insufficiently clear; and case reports.
Data collection and extraction
Two authors independently extracted data from reviewing all titles and abstracts of the searched papers. The following information was recorded from the included trials: first author, year of publication, number of participants. Basic data about gender, age, APACHE II score, and C-reactive protein (CRP, mg/L) were extracted and analyzed. To compare the clinical outcomes of the endoscopic and surgical step-up approach groups, data on mortality and MOF, intra-abdominal bleeding, PF, new-onset diabetes or impaired glucose tolerance, exocrine insufficiency, and LOS were extracted. We used a formula adopted by previous studies to acquire the mean and standard deviation (16) . According to these criteria, two independent reviewers reached a consensus when discrepancies appeared and performed identification and selection of the studies. The selection process was documented according to PRISMA criteria.
Outcome measures
The short-term outcomes were the incidence of mortality, MOF, intra-abdominal bleeding, PF, length of stay in ICU, LOS and enterocutaneous fistula. The long-term outcomes were other chronic complications, such as recurrence of pseudocysts, new-onset diabetes or impaired glucose tolerance, and exocrine insufficiency.
Quality assessment and risk of bias
Two readers independently extracted and checked the data from the enrolled studies to ensure consistency. The quality of the included RCTs, as assessed by the Cochrane Handbook for Systematic Reviews of Interventions, and quality assessment of the included retrospective trials, assessed by the Newcastle-Ottawa Scale. Egger test, was used to assess publication bias, which was based on the OR of mortality in necrotizing pancreatitis.
Statistical analyses
For alignment outcomes, the number of patients for each treatment outcome was used in the analysis. Odds ratios (ORs and variances) for the 10 different complications comparing endoscopic and MIS approaches were calculated for each comparative study. The heterogeneity of all test parameters was examined with the Q-statistic test and I 2 index for sensitivity and specificity. Heterogeneity was considered to be significant if p < 0.10 (Q statistic) or I random effects model, after which the results were transformed back into the OR metric. The random-effects model was used regardless of whether there was significant random-effects variation. Fixed effects model is performed as a sensitivity test. The study included both randomized clinical trials and observational studies, and we conducted subgroup analyses according to the study characteristics (RCT or not) in order to analyze sources of heterogeneity. All statistical analyses were conducted using STATA 14.0. For dichotomous outcomes in the extracted data, OR and 95%CI were calculated, and WMD (Weighted Mean Difference) were used for continuous outcomes. When the interquartile range and median were given instead of the standard deviation (SD), we converted the data using the Hozo algorithm to estimate the standard deviation. We performed sensitivity analysis to assess the stability of the results and investigate the influence of each study by omitting a single study sequentially. Publication bias was shown by funnel plot.
Results

Included trial characteristics and quality assessment
The initial 1563 citations were identified based on a study of the subject and a summary of the literature, of which 784 articles were thereafter excluded because of duplication. After reviewing the title and abstract of the remaining 53 studies, only 14 full-text studies were evaluated for further assessment, and five records were excluded due to incomplete data. Eventually, 9 clinical studies were consistent with the inclusion requirements (17) (18) (19) (20) (21) (22) (23) (24) (25) . A detailed study flow-diagram is shown in Fig. 1 . The quality of the included RCTs, as assessed by the Cochrane Handbook for Systematic Reviews of Interventions, is displayed in Table 2 , and the quality assessment of the included retrospective trials, assessed by the Newcastle-Ottawa Scale, is summarized in Table 3 . Table 3 Quality assessment of included studies: quality of the included prospective studies. (Fig. 2.b ).
Ref
Short-term outcomes: PF, intra-abdominal bleeding, enterocutaneous fistula.
Six studies (17-19, 21, 23-24) recorded pancreatic fistulas were external (i.e., pancreaticocutaneous fistulas) with no heterogeneity being observed (I 2 =0.0%, P=0.904) among them. After aggregation of the data, we found that the endoscopic approach was associated with a significant reduction in the rate of PF on the RCT studies (OR=0.09, 95%CI 0.02-0.32, P<0.001), retrospective studies (OR=0.14, 95%CI 0.02-0.85, P=0.033) and whole studies (OR=0.10, 95%CI 0.04-0.30, P<0.001) (Fig. 2.c) . Eight research report the intra-abdominal bleeding (17) (18) (19) (20) (21) (22) (23) (24) with no heterogeneity being observed (I 2 =0.0%, P=0.489) among them. There was no significant reduction on the RCT studies (OR=1.02, 95%CI 0.39-2.67, P=0.972), retrospective studies (OR=0.40, 95%CI 0.14-1.17, P=0.094) and whole studies (OR=0.67, 95%CI 0.33-1.37, P=0.271) (Fig. 2.d) . And eight studies about enterocutaneous fistula (17) (18) (19) (20) (21) (22) (23) (24) (25) (Fig. 2.e) in the endoscopic approach, the differences were not significant.
Medical resources: Length of stay in hospital, Days in intensive care.
Although all studies compared the endoscopic procedure (n=170) with the MIS procedure (n=188) with median or mean hospital stays and Days in intensive care, some studies provide median and IQR that makes analysis impossible. Six studies (17, 19-20 
Long-term outcomes: recurrence of pseudocyst.
A long-term prognosis is also a crucial criterion for determining the quality of treatment methods. A small number of patients relapsed with pancreatic cysts in all studies over 6 months of follow-up. Five studies (18-19, 21, 23, 24) were analysis with no heterogeneity among them (I 2 =46.7%, P=0.111), there is no significant difference between the two treatment methods on the retrospective studies (OR=1.12, 95%CI 0.18-7.07, P=0.906) and whole studies (OR=0.82, 95%CI 0.19-3.64, P=0.797) (Fig. 2.h )..
Long-term outcomes: New-onset diabetes, exocrine insufficiency.
Five included studies (17) (18) (19) (20) 24) provided data on endocrine insufficiency, which included 82 cases in the endoscopic approach group and 87 cases in the MIS group. Twelve out of 82 (15.85%) patients who underwent the endoscopic procedure were diagnosed with new-onset diabetes, whereas 27 out of 87 (31.03%) patients who underwent the MIS procedure were diagnosed. There is significant heterogeneity among them (I 2 =48.7%, P=0.099).A pooled analysis with follow-up durations of > 3 months showed that there were no significant differences between the two groups in the induction of endocrine insufficiency on the RCT studies (OR=0.83, 95%CI 0.27-2.48, P=0.732), retrospective studies (OR=0.12, 95%CI 0.02-0.59, P=0.009) and whole studies (OR=0.30, 95%CI 0.08-1.14, P=0.077) (Fig. 2.i) . Data regarding exocrine insufficiency were available in four trials (17-18, 20, 24) . No heterogeneity was found among them (I 2 =36.9%, P=0.191).There were no significant differences found in the induction of exocrine insufficiency between the endoscopic and MIS groups on the RCT studies (OR=0.38, 95%CI 0.02-8.64, P=0.546), retrospective studies (OR=0.73, 95%CI 0.21-2.52, P=0.622) and whole studies (OR=0.75, 95%CI 0.27-2.12, P=0.588) (Fig. 2.j) .
Subgroup and Sensitivity analysis
Subgroup analyses were performed to evaluate whether the ORs of outcome measures were different among the study characteristics. There were significantly difference in MOF on the RCT studies only but no significant difference on the retrospective studies. Based on stratified analysis results of the RCT and retrospective studies, there is no difference between endoscopic and MIS. Sensitivity analysis was performed to assess the stability of pooled results. Among the seven studies, the significant results were not obviously altered after sequentially omitting each study. In the pooled results comparing the incidence of mortality, after excluding the Sandra van Brunschot, the heterogeneity decreased significantly (OR=0.719, 95%CI=0.277-1.865, P=0.497, I² =28%) and showed that there was no significant difference in preventing the incidence of mortality between the two groups; hence, it was regarded as a result of heterogeneity. Likewise, the other studies were considered as the source of heterogeneity because the heterogeneity significantly changed and showed that there was no significant difference in preventing the incidence of mortality between the two groups by excluding each of these studies in the pooled results comparing the incidence of mortality. A sensitivity analysis was conducted to determine whether the exclusion of this study would alter the result, and exclusion of this study from the metaanalysis did not substantially influence the results. In this part of the study, two RCTs and five retrospective trials were included. The funnel plots of the ORs for mortality and necrotizing pancreatitis were used to assess publication bias. Egger test results showed Pr > jzj=1.00 (Fig. 3) . Therefore, we believe that the risk of publication bias is low in this meta-analysis. 
Discussion
Summary of the main results
With the rising incidence of INP, feasible and effective management is greatly needed (26) . At present, endoscopic and MIS procedures play an important role in the treatment of INP (27) . It is hard to say which is more effective. However, there have been many studies about the preponderance of endoscopic procedures recently (28) (29) (30) , including the direct single use of endoscopic and the combined endoscopic and percutaneous approach. However, these documents have their own shortcomings, such as the small number of research objects and no multicenter research. Therefore, the focus of this analysis was to evaluate the efficacy of two different approaches in the treatment of INP. The meta-analysis identified seven published studies that assessed the outcomes of patients with INP who underwent the endoscopic or MIS approach. There are few published RCTs because of the lack of patients, necessary equipment, and technically savvy experts in addition to the presence of uncontrollable risk during treatment. Much evidence of effects cannot be adequately studied in randomized trials, such as long-term and rare outcomes. Therefore, we analyzed all cohort studies in this study. For the main results, there was no notable difference in mortality and MOF between the two methods in patients with infected necrosis. Improved shortterm outcomes, including reduced incidence of PF and decreased LOS, were detected in patients who underwent an endoscopic approach. Regarding the outcome of newonset diabetes and exocrine insufficiency, the endoscopic procedure reported no better outcome of exocrine insufficiency (follow-up time >2 months) when compared to patients who underwent an MIS procedure. There has been great controversy between pancreatitis and diabetes. Malka D's study in 2000 suggested that long-term development of pancreatic insufficiency was not reliant on the type of surgical procedure but instead may be related to the features of chronic pancreatitis (31). Shen HN's matched controls arrived at the conclusion that the risk of diabetes increases by twofold after INP (32).
Comparison with previous studies
In consideration of the long history of medical development and AP's widespread application, the best treatment has obviously improved. It was recognized that conservative treatment of INP was the major choice rather than surgery before the twentieth century (33 
Limitations of the study
However, despite a comprehensive analysis, there are also many limitations that should be taken into consideration in our meta-analysis. First, the studies included in the metaanalysis were not all RCTS. Second, in the literatureincluded studies, every study in the endoscopic approach is not completely similar. Weather the location of WON adjacent to the GI lumen affects the final curative effect is still unknown. Third, because of the different intervention timings, it was difficult to avoid these slight differences. Fourth, partial missing information in a few articles may lead to biased results. We have attempted to contact investigators or study sponsors to verify key study characteristics and obtain missing numerical outcome data. In addition to the portions of the studies that did not directly provide means and standard deviations, the author used Hozo's algorithm to estimate those values; this may have introduced bias. Moreover, clinical and method logical heterogeneities were observed in several parameters in the meta-analysis given the variation in surgical techniques, patient composition, and preferences among different centers. Finally, the assessment indices of the postoperative clinical complications were not unified, and differences existed in with each operative technique, such as operation surgical skills, incision length, and operation time, which might also affect the results. True heterogeneity and poor methodological quality could also lead to an asymmetric plot (43, 44) . In the future, larger, higher quality clinical trials comparing the two approaches should be expected, and we will conduct a more detailed subgroup analysis to explore the sources of heterogeneity to obtain a more reliable conclusion.
Conclusion
In summary, there is no difference in therapeutic effect between the two methods in terms of long-term effects. But refer to the short outcomes, we demonstrated that improved short-term outcomes, including PF and LOS, were recorded in patients who underwent endoscopic approach. There is a great need for more RCTs to confirm these advantages. In addition, future studies will be required to further define the optimal time and various techniques for the endoscopic procedure.
